Litcius/Paper detail

Low-dose rifaximin prevents complications and improves survival in patients with decompensated liver cirrhosis

Xin Zeng, Xia Sheng, Peiqin Wang, Haiguang Xin, Yibin Guo, Yong Lin, Jia-Wei Zhong, Cheng-Zhi He, Jie Yin, Taotao Liu, Weijuan Ma, Xiao Xiao, Pei‐Mei Shi, Zong-Li Yuan, Ling Yang, Xiong Ma, Jianming Xu, Xizhong Shen, Changqing Yang, Xuan Zhu, Nonghua Lv, Wei‐Fen Xie

2021Hepatology International39 citationsDOI

Topics & Concepts

RifaximinMedicineHepatic encephalopathyCirrhosisGastroenterologyInternal medicineSpontaneous bacterial peritonitisAscitesLiver transplantationIncidence (geometry)TransplantationHepatologyAdverse effectClinical endpointRandomized controlled trialAntibioticsPhysicsBiologyOpticsMicrobiologyTravel-related health issuesLiver Disease and TransplantationOrgan Transplantation Techniques and Outcomes
Low-dose rifaximin prevents complications and improves survival in patients with decompensated liver cirrhosis | Litcius